- Home
- APLM vs CSCI Comparison
APLM vs CSCI Comparison
Compare APLM & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- CSCI
- Stock Information
- Founded
- APLM 2016
- CSCI 1990
- Country
- APLM United States
- CSCI Canada
- Employees
- APLM N/A
- CSCI N/A
- Industry
- APLM Blank Checks
- CSCI
- Sector
- APLM Finance
- CSCI
- Exchange
- APLM Nasdaq
- CSCI NYSE
- Market Cap
- APLM 6.9M
- CSCI 10.6M
- IPO Year
- APLM N/A
- CSCI 1996
- Fundamental
- Price
- APLM $5.33
- CSCI $3.53
- Analyst Decision
- APLM
- CSCI
- Analyst Count
- APLM 0
- CSCI 0
- Target Price
- APLM N/A
- CSCI N/A
- AVG Volume (30 Days)
- APLM 26.7K
- CSCI 2.4K
- Earning Date
- APLM 08-13-2025
- CSCI 08-12-2025
- Dividend Yield
- APLM N/A
- CSCI N/A
- EPS Growth
- APLM N/A
- CSCI N/A
- EPS
- APLM N/A
- CSCI N/A
- Revenue
- APLM $198,000.00
- CSCI $9,030,000.00
- Revenue This Year
- APLM $415.15
- CSCI N/A
- Revenue Next Year
- APLM N/A
- CSCI N/A
- P/E Ratio
- APLM N/A
- CSCI N/A
- Revenue Growth
- APLM N/A
- CSCI 36.51
- 52 Week Low
- APLM $4.47
- CSCI $1.96
- 52 Week High
- APLM $35.98
- CSCI $7.43
- Technical
- Relative Strength Index (RSI)
- APLM 44.49
- CSCI N/A
- Support Level
- APLM $5.33
- CSCI N/A
- Resistance Level
- APLM $6.56
- CSCI N/A
- Average True Range (ATR)
- APLM 0.54
- CSCI 0.00
- MACD
- APLM -0.05
- CSCI 0.00
- Stochastic Oscillator
- APLM 33.11
- CSCI 0.00
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.